Difluprednate Ophthalmic Market

Difluprednate ophthalmic is used to treat eye swelling and pain after eye surgery. Difluprednate ophthalmic is in a class of medications called corticosteroids. It works by stopping the release of certain natural substances that cause swelling and pain.

Difluprednate ophthalmic comes as an emulsion (liquid) to apply to the eye. It is usually applied to the affected eye(s) 4 times a day beginning 24 hours after surgery and continuing for 2 weeks, and then 2 times a day for 1 week.

Difluprednate Ophthalmic Market contains market size and forecasts of Difluprednate Ophthalmic in global, including the following market information:

• Global Difluprednate Ophthalmic Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Difluprednate Ophthalmic Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Difluprednate Ophthalmic companies in 2021 (%)

The global Difluprednate Ophthalmic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Patented Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Difluprednate Ophthalmic include Novartis, Ajanta Pharma, Sun Pharmaceutical, General Pharmaceuticals, Orchidia and Innovative Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Difluprednate Ophthalmic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Difluprednate Ophthalmic Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Difluprednate Ophthalmic Market Segment Percentages, by Type, 2021 (%)

• Patented Drug
• Generic Drug

Global Difluprednate Ophthalmic Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Difluprednate Ophthalmic Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Drugs Store
• Online

Global Difluprednate Ophthalmic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Difluprednate Ophthalmic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Difluprednate Ophthalmic revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Difluprednate Ophthalmic revenues share in global market, 2021 (%)
• Key companies Difluprednate Ophthalmic sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Difluprednate Ophthalmic sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Ajanta Pharma
• Sun Pharmaceutical
• General Pharmaceuticals
• Orchidia
• Innovative Pharmaceuticals